News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Parker Albert P
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 18,864 shares
@ $0
Paid exercise price by delivering 5,463 shares
@ $0.5965, valued at
$3.3k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 170,000 shares
@ $0 |
|
| 02/15/2022 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 shares
@ $0
Granted 200,000 options to buy
@ $2.7, valued at
$540k
|
|
| 12/15/2020 |
4
| Parker Albert P (COO) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 5,586 shares
@ $0 |
|
| 08/05/2020 |
4
| Parker Albert P (COO) has filed a Form 4 on OncoCyte Corp|
Txns:
| Bought 5,000 shares
@ $1.3296, valued at
$6.6k
|
|
| 02/12/2020 |
4
| Parker Albert P (COO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 204,000 options to buy
@ $2.63, valued at
$536.5k
|
|
| 03/18/2019 |
4
| Parker Albert P (COO) has filed a Form 4 on OncoCyte Corp|
Txns:
| Granted 200,000 options to buy
@ $3.52, valued at
$704k
|
|
|
|